Clinical Trial: Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Clinical Trial: Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian CancerSponsor and Collaborators
AGO Study Group
ARCAGY/ GINECO GROUP
MITO
Arbeitsgemeinschaft Gynaekologische Onkologie Austria
GlaxoSmithKline
medac GmbH
Contact
Contact: Philipp Harter, MD
+49 (0)611 880 4670
office-wiesbaden@ago-ovar.de
Contact: Andreas du Bois, Professor
+49 (0)611 880 4670
office-wiesbaden@ago-ovar.de
ClinicalTrials.gov Identifier
NCT01166737
